Bicycle Therapeutics Plc ADR (NASDAQ:BCYC) price on Thursday, July 03, fall -0.13% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.43.
A look at the stock’s price movement, the close in the last trading session was $7.44, moving within a range at $7.26 and $7.58. The beta value (5-Year monthly) was 1.472. Turning to its 52-week performance, $28.67 and $6.10 were the 52-week high and 52-week low respectively. Overall, BCYC moved -10.48% over the past month.
Bicycle Therapeutics Plc ADR’s market cap currently stands at around $514.16 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-01.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BCYC is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend BCYC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BCYC’s current price about -4.48% and -8.57% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.95, while 7-day volatility ratio is 6.58% and 6.04% in the 30-day chart. Further, Bicycle Therapeutics Plc ADR (BCYC) has a beta value of 1.42. Analysts have given the company’s stock an average 52-week price target of $17, forecast between a low of $17 and high of $17. Looking at the price targets, the low is -128.8% off current price level while to achieve the yearly target high, price needs to move -128.8%. Nonetheless, investors will most likely welcome a -128.8% jump to $17 which is the analysts’ median price.
If we refocus on Bicycle Therapeutics Plc ADR (NASDAQ:BCYC), historical trading data shows that trading volumes averaged 0.35 over the past 10 days and 350.92K over the past 3 months. The company’s latest data on shares outstanding shows there are 69.20 million shares.
The 11.18% of Bicycle Therapeutics Plc ADR’s shares are in the hands of company insiders while institutional holders own 57.29% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.48 million on 2025-06-13, giving us a short ratio of 9.95. The data shows that as of 2025-06-13 short interest in Bicycle Therapeutics Plc ADR (BCYC) stood at 684.0 of shares outstanding, with shares short falling to 3.33 million registered in 2025-05-15. Current price change has pushed the stock -63.38% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BCYC stock continues to rise going into the next quarter.
